← Back to headlines
Mizuho Lifts Price Target on BridgeBio Pharma (BBIO) to $106 From $91
Mizuho has increased its price target for BridgeBio Pharma (BBIO) from $91 to $106, explaining the factors contributing to this revised target.
31 Mar, 15:06 — 31 Mar, 15:06
Sources
Showing 1 of 1 sources
